• People

    Advanced Search

  • Services
  • All Services

  • Have you been injured using the Alere INRatio blood clot monitoring system? If so, you may be entitled to compensation.

    The Alere INRatio recall was issued by the FDA because the blood clot monitoring systems were shown to deliver incorrect test results. This is a Class 1 recall, the most serious classification issued by the FDA for medical device product failures because inaccurate INR test levels could result in serious injury or death.

    The recall affects Alere’s INRatio and INRatio2 PT/INR Monitoring Systems including:

    • 125,576 test strip kits (12 count),
    • 24,783 test strip kits (48 count), and,
    • 236,345 INRatio or INRatio2 monitors.*

    * See below for a complete list of recalled devices

    The Alere patient INR tests measure blood coagulation activity. If the blood clot factor (INR level), is too low, a patient could suffer excess bleeding. If it is too high there is a risk of blood clot formation (thrombosis) that could block the circulatory system. The recalled test kits are known to have delivered inaccurate results putting patients at risk for serious injury or death including, among other conditions, subdural hematoma, hemorrhagic stroke, uncontrollable bleeding, organ damage, or a related injury.

    If you or someone in your family has used one or more of the devices affected by the Alere INRatio recall to test and control anticoagulation (blood clot) therapy you should consult your doctor immediately. It is important that you request a new blood test for anticoagulation clotting factors to make sure your results are normal. You should also seek out legal counsel to protect your interests in the event you have, or may suffer an injury from use of the recalled Alere test kits or monitors.

    Stark & Stark attorneys are actively seeking and filing legal claims for those injured or killed from use of recalled Alere INRatio test kits, and INRatio2 PT/INR Monitoring Systems. Please contact your doctor first to get retested, and then contact Stark & Stark for assistance.

    What is wrong with the Alere INRatio Testing Devices?

    Background

    Alere INRatio test strips and monitors measure a patient’s International Normalized Ratio (INR) which is the blood factor that shows how quickly your blood clots. The devices are generally prescribed for patients taking Coumadin (warfarin) or other blood thinning medications. The tests are necessary to maintain normal blood clotting activity in affected patients. Depending on the test results, medication dosage is changed to normalize the results. The thinner your blood, the longer it takes to clot, the higher your INR value. The thicker your blood, the faster it clots, the lower your INR value. High INR can lead to uncontrollable bleeding, while low INR can lead to a risk of blood clot or stroke.

    Device Failures

    Under certain conditions, the Alere INRatio and INRatio2 PT/INR Monitoring Systems were found to generate inaccurately low INR readings. Simply stated, the systems were inaccurately reading INR levels in patients, which resulted in dangerously inaccurate dosage changes, which put patients at a high risk for potentially deadly bleeding events. Essentially the revised or continued medication dosage was thinning already thin blood to dangerous levels.

    Alere INRatio Recall List

    Based on thousands of patient complaints of injuries (including cranial bleeding, stroke and death), all of the following Alere INRatio and INRatio2 PT/INR Monitoring System monitors and test strips manufactured and distributed from April 1, 2008 to July 8, 2016, were recalled:

    • Alere INRatio2 PT/INR Professional Monitoring System (55128A)
    • Alere INRatio2 PT/INR Home Monitoring System (0200432)
    • Alere INRatio2 Replacement Monitor (Home) (0200457)
    • Alere INRatio2 PT/INR Professional Testing System (0200431)
    • Alere INRatio/INRatio2 PT/INR Test Strips (99007EU, 99007G1, 99007G3,99007G5, 99007G7, 99008EU, 99008G1, 99008G3, 99008G5,99008G7)
    • Alere INRatio PT/INR System Professional (0100004)
    • Alere INRatio Prothrombin Time (PT) Monitoring System (0100007)
    • Alere INRatio Replacement Monitor (0100137)
    • Alere INRatio PT/INR Test Strips (0100071, 0100139)

    Do I have a claim related to use of the Alere INRatio recalled products?

    You may have a claim if you or someone in your family used one or more of these devices during the recall years of 2008-2016 and suffered an unexpected injury or deadly bleeding event.

    Stark & Stark attorneys are actively negotiating Alere INRatio and INRatio2 PT/INR Monitoring System settlements and evaluating claims for Alere INRatio and INRatio2 PT/INR Monitoring System lawsuits on behalf of patients injured or killed from use of the potentially defective devices. We are committed to holding drug and medical device manufacturers liable when their products improperly endanger the public and put patients at a high risk of injury or death.

    Our Alere INRatio and INRatio2 PT/INR Monitoring System lawyers are experienced in medical device and pharmaceutical product failure negotiating strategies that get the best results for our clients.

    If you or someone in your family has been affected by the INRatio recall, you should contact us to assess your eligibility for a claim against the manufacturers of the Alere INRatio test kits and monitors and to help you understand the Alere INRatio and INRatio2 PT/INR Monitoring System lawsuit and potential settlement process.

    Speak with an Experienced Attorney Today

    Firm Highlights

    Stark & Stark’s Thomas S. Onder, Esq. Receives 2026 ICSC Trustees’ Distinguished Service Award

    Stark & Stark is proud to announce that Thomas S. Onder, Esq., Shareholder and Chair of the Firm’s Shopping Center & Retail Development...

    Stark & Stark’s Joseph H. Lemkin Esq., Named 2026 Professional Lawyer of the Year for the Jewish Bar Association of New Jersey

    Stark & Stark is proud to announce that Joseph H. Lemkin Esq. has been selected by the New Jersey Commission on Professionalism in the Law as...

    Our Values Remain: A Message on the Closing of Diversity Lab

    Stark & Stark is saddened and disappointed to learn that Diversity Lab, the organization that created and manages the Mansfield Certification...

    Congratulations to Shareholder Bhaveen R. Jani, Esq. on his Installation as Treasurer of the Middlesex County Bar Foundation

    Stark & Stark is proud to announce that Shareholder Bhaveen R. Jani, Esq. has been installed as Treasurer of the Middlesex County Bar Foundation,...

    Denise Mariani, Esq., and Jonathan Lauri, Esq. Secure $750,000 Jury Verdict Against Hamilton Healthcare and Rehabilitation Center

    It is our pleasure to announce that Denise Mariani, Esq., and Jonathan Lauri, Esq., secured a $750,000 jury verdict on behalf of a nursing home...

    Stark & Stark Welcomes 2026 Summer Law Clerks

    Stark & Stark is proud to announce its 10th Annual Summer Law Clerk Program. Five Summer Law Clerks will join the firm from June through July...

    Retail Development Team Secures Major Recovery for Landlord Client Amid Bankruptcy Dispute

    Our Shopping Center and Retail Development Group recently secured a multi-million-dollar settlement for a commercial landlord client' s property...

    Jeffrey A. Krawitz, Esq. and Catherine Foley, Esq. Secure $950,000 Settlement in Surgical Malpractice Matter

    Jeffrey A. Krawitz, Esq. and Catherine Foley, Esq. recently secured a confidential $950,000 settlement in a surgical malpractice case. “This...

    Victoria Wilton, Esq. Selected to Serve on New Jersey State Bar Association Family Law Executive Committee

    We are proud to announce that Victoria Wilton, Esq. has been selected to serve on the New Jersey State Bar Association Family Law Executive Committee...

    Stark & Stark Joins Growing Coalition of Law Firms in Defense of Constitutional Principles and the Independence of the Legal Profession

    Stark & Stark has joined hundreds of fellow law firms across the country in filing an amicus brief supporting Perkins Coie, WilmerHale, Jenner...

    Stark & Stark Attorneys Recognized as New Jersey “Super Lawyers” and “Rising Stars” in 2026

    Stark & Stark is pleased to announce that 15 of its attorneys have been selected for inclusion in the list of 2026 New Jersey Super Lawyers,...

    Bruce Stern, Esq. Secures $1,000,000 Settlement in Motor Vehicle Collision Case

    Bruce Stern, Esq. recently secured a $1,000,000 settlement in a motor vehicle collision case.* “This case highlights how quickly things can go...